Manufacturing optimization is projected to expand batch output by ~50%, improving supply reliability and supporting higher-throughput PSMA PET imaging services. Increased radioactivity extends shelf ...

Cancer death rates in the UK have fallen to a historic new low, Cancer Research UK has announced. The charity, which analysed ...

Around 247 in every 100,000 people in the UK are thought to die from cancer in any given year ...

Cancer Research UK data shows death rates have fallen 11% in the last decade overall with significant falls in cancers such as breast cancer and cervical cancer ...

Shares rebound from Monday’s $90b wipeout; oil back to $US90 after earlier surge toward $120; Fortescue completes Alta buy; Air New Zealand axes guidance over conflict. Follow live.

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...

Recently published Neuroendocrine Carcinoma Market Insights report includes a comprehensive understanding of current treatment practices, neuroendocrine carcinoma emerging drugs, market share of ...

'Thousands more people today can make memories, reach milestones, and spend precious time with their loved ones' ...

Cancer death rates in the UK have hit a historic new low, according to data from cancer charity.

As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) ...

The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic capabilities. Advancements in targeted therapies and immunotherapies ...

Shares rebound from Monday’s $90b wipeout; oil prices tumble after Trump’s signal; Woodside starts drilling in Mexico; CSL plans US expansion; Orica to cut $100m in costs. Follow live.